In patients with atrial fibrillation, Boston Scientific's Watchman heart implant performed better than the anticoagulant warfarin in terms of quality-of-life indicators after one year, according to a study published in the Journal of the American College of Cardiology. The study, however, also found that patients who had the implant had a higher risk for serious bleeding.

Related Summaries